>
Trump's Bold 2016 Campaign Talking Point That Ignited Nationwide Controversy
Warfare is beginning to look more like a science fiction film.
Muscle-powered mechanism desalinates up to 8 liters of seawater per hour
Student-built rocket breaks space altitude record as it hits hypersonic speeds
Researchers discover revolutionary material that could shatter limits of traditional solar panels
In case you missed it, Ben Affleck just dropped the best talk on AI and where we're heading:
LG flexes its display muscle with stretchable micro-LED screen
LiFePO4 Charging Guidelines: What is 100%? What is 0%?! How to Balance??
Skynet On Wheels: Chinese Tech Firm Reveals Terrifying Robo-Dog
Energy company claims its new fusion technology can provide heat and power to 70,000 homes:
Wi-Fi Can be Used to Influence Brainwaves, Has Potential for Hypnotic Effects and Social Engineering
Startups Like Neuralink And Science Corp. Are Aiming To Help The Blind See Again
Known as "histotripsy," the method and machinery have already been tested successfully in animals and humans, and has just been approved for use by the FDA.
HistoSonics is a company founded in 2009 to create an ultrasound device that both screens for tumors and administers histotripsy. It was born from the efforts of scientists at the University of Michigan who co-founded the firm.
"Histotripsy is an exciting new technology that, although it is in early stages of clinical use, may provide a noninvasive treatment option for patients with liver cancer. Hopefully it can be combined with systemic therapies for a synergistic therapeutic effect," said Mishal Mendiratta-Lala, professor of radiology with Michigan Medicine.
Mendiratta-Lala was the principal investigator of an FDA human trial started in 2021 which confirmed that HistoSonic's device, called Edison, can destroy cancer tumors.